Can GLP-1 Drugs Make You Go Blind? NAION, Retinopathy, and the Evidence
Explore the evidence behind GLP-1 vision-loss headlines: semaglutide's rare NAION warning, diabetic retinopathy data, and why the two eye conditions differ.
Research Use Only: This article reports on published clinical and regulatory evidence as of September 24, 2026. It is educational information, not medical advice or a recommendation to use any product. BetterBio Synthesis materials are for qualified laboratory research only, not human or veterinary use.
“GLP-1 drugs can make you go blind” is a headline that hides two different questions. One concerns a rare optic-nerve condition called non-arteritic anterior ischemic optic neuropathy, or NAION. The other concerns diabetic retinopathy, a disease of the retina that can worsen as blood glucose changes. They are not the same event, and evidence for one cannot be used as proof of the other.